Literature DB >> 6398015

Further lymphocyte characterization in the central nervous system in multiple sclerosis.

U Traugott, C S Raine.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6398015     DOI: 10.1111/j.1749-6632.1984.tb14788.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  12 in total

Review 1.  Natural killer cells and their receptors in multiple sclerosis.

Authors:  Gurman Kaur; John Trowsdale; Lars Fugger
Journal:  Brain       Date:  2012-06-25       Impact factor: 13.501

Review 2.  The role of natural killer cells in curbing neuroinflammation.

Authors:  Benjamin M Segal
Journal:  J Neuroimmunol       Date:  2007-09-29       Impact factor: 3.478

Review 3.  Characterization and distribution of lymphocyte subpopulations in multiple sclerosis plaques versus autoimmune demyelinating lesions.

Authors:  U Traugott
Journal:  Springer Semin Immunopathol       Date:  1985

4.  CSF T-cell subsets in multiple sclerosis: relationship to cerebrospinal fluid myelin basic protein and clinical activity.

Authors:  A Salmaggi; L LaMantia; C Milanese; G Bianchi; M Eoli; A Campi; A Nespolo
Journal:  J Neurol       Date:  1989-09       Impact factor: 4.849

Review 5.  Importance of oligodendrocyte protection, BBB breakdown and inflammation for remyelination.

Authors:  Jens Watzlawik; Arthur E Warrington; Moses Rodriguez
Journal:  Expert Rev Neurother       Date:  2010-03       Impact factor: 4.618

6.  CD40-CD40L interactions induce chemokine expression by human microglia: implications for human immunodeficiency virus encephalitis and multiple sclerosis.

Authors:  Teresa G D'Aversa; Karen M Weidenheim; Joan W Berman
Journal:  Am J Pathol       Date:  2002-02       Impact factor: 4.307

Review 7.  Neuroprotective effects of the complement terminal pathway during demyelination: implications for oligodendrocyte survival.

Authors:  Cosmin A Tegla; Cornelia Cudrici; Violeta Rus; Takahiro Ito; Sonia Vlaicu; Anil Singh; Horea Rus
Journal:  J Neuroimmunol       Date:  2009-07-04       Impact factor: 3.478

8.  Human NK cells kill resting but not activated microglia via NKG2D- and NKp46-mediated recognition.

Authors:  Anna Lünemann; Jan D Lünemann; Susanne Roberts; Brady Messmer; Rosa Barreira da Silva; Cedric S Raine; Christian Münz
Journal:  J Immunol       Date:  2008-11-01       Impact factor: 5.422

9.  Expansion of CD56Bright natural killer cells in the peripheral blood of multiple sclerosis patients treated with interferon-beta.

Authors:  M Saraste; H Irjala; L Airas
Journal:  Neurol Sci       Date:  2007-06-30       Impact factor: 3.307

10.  Increased HLA-E expression in white matter lesions in multiple sclerosis.

Authors:  Pascal F Durrenberger; Louise V Webb; Malcolm J W Sim; Richard S Nicholas; Daniel M Altmann; Rosemary J Boyton
Journal:  Immunology       Date:  2012-12       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.